SEQSTER partners with Antidote Technologies for clinical trial enrollment

Antidote Applied sciences, a digital affected person engagement firm, introduced it’s partnering with SEQSTER, a multidimensional healthcare information platform, to determine sufferers for scientific trials and enhance trial timelines.

Antidote presents a scientific trial patient-recruitment platform that features affected person screening and help companies. 

The corporate will leverage SEQSTER’s working system to raised match sufferers to scientific trials based mostly on their genomic information, way of life components and medical historical past.

“Partnering with SEQSTER permits us to boost our precision recruitment course of with unparalleled information integration capabilities, guaranteeing that we will extra successfully determine appropriate contributors and scale back the time it takes to carry new remedies to market,” Samantha Veeck, co-CEO of Antidote, stated in a press release.

THE LARGER TREND

In December, San Diego-based SEQSTER partnered with Palo Alto-based real-world information platform Atropos Well being to enhance variety and inclusion in scientific trials by creating turnkey affected person registries to speed up the era of proof. 

In March, SEQSTER partnered with the A number of Sclerosis Affiliation of America to make use of information to carry collectively individuals residing with MS, researchers and care facilities nationwide. 

Three months later, decentralized scientific trial firm Thread and SEQSTER partnered to entry real-world information for all times science enterprises, researchers and sufferers. 

One other firm targeted on enhancing the scientific trial expertise is oncology-focused digital well being firm Flatiron Well being, which Roche acquired in 2018. 

In Could, Flatiron introduced a strategic collaboration with the Affiliation of Most cancers Care Facilities to advertise entry to scientific trials locally setting, enhance scientific research effectivity and improve the gathering of study-related information. 

Scientific trial startup Inato, the Digital Drugs Society (DiMe), scientific trial tech firm Science 37 and tech-enabled scientific trial platform Paradigm are additionally gamers within the house.